deltatrials
Active Not Recruiting NA INTERVENTIONAL 2-arm NCT04960787

Financial Navigation Program to Improve Understanding and Management of Financial Aspects of Cancer Care for Patients and Their Spouses (CREDIT)

A Randomized Trial Addressing Cancer-Related Financial Hardship Through Delivery of a Proactive Financial Navigation Intervention (CREDIT)

Sponsor: National Cancer Institute (NCI)

Conditions Hematopoietic and Lymphoid Cell Neoplasm Metastatic Malignant Solid Neoplasm Recurrent Malignant Solid Neoplasm
Interventions Educational Intervention Patient Navigation Quality-of-Life Assessment Questionnaire Administration
Updated 15 times since 2021 Last updated: Mar 11, 2026 Started: Oct 12, 2021 Primary completion: Sep 1, 2026 Completion: Oct 1, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04960787, this NA trial focuses on Hematopoietic and Lymphoid Cell Neoplasm and Metastatic Malignant Solid Neoplasm and remains ongoing. Sponsored by National Cancer Institute (NCI), it has been updated 15 times since 2021, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Sep 2021 – ~Oct 2021 · 30 days · monthly snapshot~Oct 2021 – ~Dec 2021 · 2 months · monthly snapshot~Dec 2021 – ~Apr 2022 · 4 months · monthly snapshot~Apr 2022 – ~Jan 2023 · 9 months · monthly snapshot~Jan 2023 – ~Feb 2023 · 31 days · monthly snapshot~Feb 2023 – ~May 2023 · 3 months · monthly snapshot~May 2023 – ~Sep 2023 · 4 months · monthly snapshot~Sep 2023 – ~Apr 2024 · 7 months · monthly snapshot~Apr 2024 – ~Jun 2024 · 2 months · monthly snapshot~Jun 2024 – ~Jul 2024 · 30 days · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~May 2025 · 8 months · monthly snapshot~May 2025 – ~Sep 2025 · 4 months · monthly snapshot~Sep 2025 – ~Mar 2026 · 6 months · monthly snapshot~Mar 2026 – present · 5 months · monthly snapshot

Change History

15 versions recorded

  1. Mar 2026 — Present [monthly]

    Active Not Recruiting NA

  2. Sep 2025 — Mar 2026 [monthly]

    Active Not Recruiting NA

  3. May 2025 — Sep 2025 [monthly]

    Active Not Recruiting NA

    Status: Recruiting → Active Not Recruiting

  4. Sep 2024 — May 2025 [monthly]

    Recruiting NA

  5. Jul 2024 — Sep 2024 [monthly]

    Recruiting NA

▶ Show 10 earlier versions

  1. Jun 2024 — Jul 2024 [monthly]

    Recruiting NA

  2. Apr 2024 — Jun 2024 [monthly]

    Recruiting NA

  3. Sep 2023 — Apr 2024 [monthly]

    Recruiting NA

  4. May 2023 — Sep 2023 [monthly]

    Recruiting NA

  5. Feb 2023 — May 2023 [monthly]

    Recruiting NA

  6. Jan 2023 — Feb 2023 [monthly]

    Recruiting NA

  7. Apr 2022 — Jan 2023 [monthly]

    Recruiting NA

  8. Dec 2021 — Apr 2022 [monthly]

    Recruiting NA

  9. Oct 2021 — Dec 2021 [monthly]

    Recruiting NA

    Status: Not Yet Recruiting → Recruiting

  10. Sep 2021 — Oct 2021 [monthly]

    Not Yet Recruiting NA

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Cancer Institute (NCI)
  • SWOG Cancer Research Network
Data source: SWOG Cancer Research Network

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Albuquerque, United States , Alton, United States , Ames, United States , Ann Arbor, United States , Antioch, United States , Appleton, United States , Asheboro, United States , Augusta, United States , Aurora, United States , Ballwin, United States and 199 more locations